Timothy W Schacker

9PUBLICATIONS
73CO-AUTHORS
Innate immunityEpidemiological modellingEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomedical engineering not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 16, 2026
Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infection.

Peter A Crawford, Joshua Rhein, Jeffrey G Chipman

|May 08, 2025
Wastewater Measures of SARS-CoV-2 Accurately Predict Frequency of Symptomatic Infections in the Community.

Charles R Doss, Mark J Osborn, Stacey Stark

|Jan 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Jesper D Gunst, Jesal Gohil, Johanthan Z Li

|Jan 11, 2024
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.

Jeffrey S Miller, Joshua Rhein, Zachary B Davis

|Dec 14, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones.

Noemia S Lima, Maryam Musayev, Timothy S Johnston

|Mar 11, 2022
Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection.

Eugène Kroon, Suthat Chottanapund, Supranee Buranapraditkun

Pageof 2

Frequent Collaborators

3 joint publications

Joshua Rhein

2 joint publications

Patrick Soon-Shiong

2 joint publications

Luis J Montaner

2 joint publications

Noemia S Lima